Trial
NCT00539513
N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
—
Condition
Obsessive-Compulsive Disorder
Intervention
N-Acetylcysteine
Why stopped
Researchers terminated study due to limited enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-04-02